Most Recent
The corporate regulator is challenging insurer IAG's claims of legal professional privilege over a technical report in proceedings over allegedly misleading loyalty discounts.
Melbourne mattress and bedding start-up Sleeping Duck has settled a suit against its former chief financial officer, who has admitted to breaching confidentiality obligations to the company by disclosing information to a competitor.
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off.
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera's bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
It faced defeat at the Full Federal Court and encountered a deadlocked High Court, still Aristocrat persisted in its seven-year fight to get patent protection for the popular Lightning Link poker machine. The long game paid off.
Regeneron and Bayer have lost their bid to block generic drug maker Sandoz from launching a biosimilar of their blockbuster eye drug Eylea.
Payday lenders BSF Solutions and Cigno have lost an appeal in action by ASIC alleging they engaged in unlicensed credit activity and charged prohibited fees, in the case's second run up to the Full Federal Court.
A judge has sent to the Full Federal Court Medibank’s fight to shield Deloitte reports into a data breach, raising concerns about how evidence from a solicitor and the health insurer's inhouse lawyer was previously treated.